AI is a powerful brainstorming tool when used correctly. Here's how to write better prompts and refine ideas more effectively ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

The update allows ChatGPT Images 2.0 to create a series of images based on one prompt. The update allows ChatGPT Images 2.0 to create a series of images based on one prompt. is a news writer who ...

On Saturday, Feb. 28, the Golden State Warriors signed Gui Santos to a $15 million, three-year contract extension, as reported by ESPN's Shams Charania. Santos has steadily improved his game since ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

YouTube is rolling out a new AI-powered playlist-generation feature that allows Premium users on iOS and Android to use text prompts to create playlists. Users can go to the Library tab, tap the “New” ...

Those incapable of drawing, or anyone who wants an accurate cartoonish portrait of themselves, are in luck, as OpenAI's ChatGPT can turn you into a caricature. With artificial intelligence becoming ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...